Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

(2011) Johnny Kao et al.   CANCER

Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer

(2010) Karen Reckamp et al.   CANCER

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

(2010) Mark E. Sharafinski et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs

(2010) Jin-Haeng Chung et al.   LUNG CANCER

Anti-cancer effects of celecoxib in head and neck carcinoma

(2010) Young-Youn Kim et al.   MOLECULES AND CELLS

Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines

(2009) Y. Haddad et al.   CLINICAL CANCER RESEARCH

Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma

(2009) M. A. St. John et al.   CLINICAL CANCER RESEARCH

Regulation of Prostaglandin Transporters in Colorectal Neoplasia

(2008) V. R. Holla et al.   Cancer Prevention Research

Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer

(2008) M. K. Sackett et al.   CLINICAL CANCER RESEARCH

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

(2008) V. A. Papadimitrakopoulou et al.   CLINICAL CANCER RESEARCH

15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma

(2008) Julio E. Celis et al.   MOLECULAR & CELLULAR PROTEOMICS